906 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
J&J (JNJ) Recalls Baby Powder Batch as FDA Finds Asbestos http://www.zacks.com/stock/news/575752/jj-jnj-recalls-baby-powder-batch-as-fda-finds-asbestos?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-575752 Oct 21, 2019 - J&J (JNJ) voluntarily recalls one lot of its baby powders, which is the subject of numerous lawsuits claiming that its talc-based products contain asbestos that causes cancer.
TEVA: Gabelli & Co ups to Buy https://www.briefing.com/in-depth-analysis/Content/Article?ArticleId=UD20191017082319 Oct 17, 2019 - Gabelli & Co issues rating change for TEVA
Five companies said to be in talks over $22 billion opioid settlement https://www.cnbc.com/2019/10/16/five-companies-said-to-be-in-talks-over-22-billion-opioid-settlement.html Oct 16, 2019 - Three major drug distributors – McKesson, AmerisourceBergen and Cardinal Health – are in discussions to pay $18 billion, while drugmaker Johnson & Johnson has offered $4 billion.
J&J (JNJ) Beats on Q3 Earnings as Sales Rise, Ups 2019 View http://www.zacks.com/stock/news/565810/jj-jnj-beats-on-q3-earnings-as-sales-rise-ups-2019-view?cid=CS-ZC-FT-analyst_blog|earnings_article-565810 Oct 15, 2019 - J&J (JNJ) comes up with encouraging third-quarter 2019 results.
Lilly Gets FDA Approval for New Oral Tablets for Migraine http://www.zacks.com/stock/news/563662/lilly-gets-fda-approval-for-new-oral-tablets-for-migraine?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-563662 Oct 14, 2019 - Eli Lilly (LLY) gets FDA approval for lasmiditan oral tablets to treat acute migraine in adults.
Jim Cramer Shares His Thoughts On Teva Pharmaceutical, MGM Resorts And More http://feeds.benzinga.com/~r/benzinga/~3/ggRLhSSoZus/jim-cramer-shares-his-thoughts-on-teva-pharmaceutical-mgm-resorts-and-more Oct 12, 2019 -

On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't like Teva Pharmaceutical Industries Ltd (NYSE: TEVA). He would sell the stock.

read more

Cramer's lightning round: MGM's gambling and sports plans are 'spectacular' https://www.cnbc.com/2019/10/11/cramer-lightning-round-mgm-has-spectacular-gambling-sports-plans.html Oct 11, 2019 - Jim Cramer takes calls and opines on viewer stock picks of the day in rapid speed.
Teva sells logistics center for $127M https://seekingalpha.com/news/3505082-teva-sells-logistics-center-127m?source=feed_news_all Oct 10, 2019 - Advancing its turnaround plan that includes the divestment of a range of assets, Teva Pharmaceutical Industries (TEVA +1.5%) has agreed to sell its Shoham-based 50,000 sq. ft. logistics center to real
Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know http://www.zacks.com/stock/news/553574/teva-pharmaceutical-industries-ltd-teva-gains-as-market-dips-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-553574 Oct 07, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $6.98 in the latest trading session, marking a +0.14% move from the prior day.
AstraZeneca's Fasenra Gets FDA Nod for Self-Administration http://www.zacks.com/stock/news/552912/astrazenecas-fasenra-gets-fda-nod-for-self-administration?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-552912 Oct 07, 2019 - The FDA approval of the self-administration option and auto-injector of AstraZeneca's (AZN) Fasenra is supported by data from the phase III GRECO study and the phase I AMES study

Pages: 12345678...91

<<<Page 3>